In summary, our data revealed AEP as a key factor contributing to cancer resistance, providing the rationale for the design of new strategies to treat resistant tumors by combining AEP inhibitors with current chemo- and radiotherapy approaches to sensitize them to genotoxic stress. The gene discussed is LGMN; the disease is cancer.